The findings from this initial stage are highly significant, as molecules that fail to meet drug-likeness criteria generally have a lower likelihood of becoming successful drug candidates and can therefore be excluded early in the selection process.
← all excerpts
A review and in silico screening of plant-derived snake venom/toxin inhibitors: ADMET, drug-likeness, and medicinal chemistry profiling.
1
—
—